• Correlation of Drug Substance Bulk Properties to Predict and Troubleshoot the Formulation of Drug Product


  • Importance of Solid Form in Formulation and Bioavailability during Research and Development


  • Solid State Modeling and Its Role in Drug Development


  • Amorphous Formulations for Solubility Enhancement: Risks and Opportunities


  • Current Practice and Future Perspective in Crystallography for API Solid Form Risk-Management


  • Application of 15N SSNMR to Differentiate and Quantify Different API Amorphous Phases in Complex Tablet Formulation


  • Crystallisation in Agrochemicals: The Good, the Bad, and the Unusual